Quick Takeaways
- This page summarizes Nir Sassi's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 23 Jan 2024, 16:15.
Nir Sassi - 22 Jan 2024 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Signature
- /s/ Nir Sassi
- Issuer symbol
- INDP
- Transactions as of
- 22 Jan 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 23 Jan 2024, 16:15:47 UTC
- Previous filing
- 20 Jan 2023
- Next filing
- 10 Oct 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Nir Sassi filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 23 Jan 2024."
What Changed
- Previous filing in this sequence was filed on 20 Jan 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INDP | Stock Option (Right to Buy) | Award | $0 | +40,000 | $0.000000 | 40,000 | 22 Jan 2024 | Common Stock | 40,000 | $1.74 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027. |